Samsung C&T’s net profit jumps 55.8 percentSamsung C&T said Wednesday its first-quarter net profit jumped 55.8 percent from a year earlier due to profitable overseas projects and shareholding gains from its affiliate.
Net profit for the three months ending March 31 stood at 346.5 billion won ($281 million) from 222.4 billion won a year earlier, the company said in a regulatory filing.
“Increased equity gains from Samsung Biologics and profitable overseas projects boosted the first-quarter net profit,” an official of Samsung C&T said.
Samsung C&T holds a 43.3 percent stake in Samsung Biologics, a biopharmaceutical unit of South Korea’s largest conglomerate Samsung Group.
Samsung C&T said its operating profit rose 39.8 percent to 147 billion won in the first quarter from 105 billion won a year ago.
Still, sales declined 5.4 percent to 6.96 trillion won from 7.35 trillion won. Shares of Samsung C&T rose 3.3 percent percent Wednesday.
More in Industry
[SHORTCUT] Is 2021 the year electric vehicles go mainstream?
Lobby groups call for leniency for Samsung's Lee
Thousands claim fraud after buying items via social media
No dial tone for 2G services on LG U+ starting in June
Ironing out an air corridor took decades